These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 8222794

  • 1. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC, Chick TW.
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [Abstract] [Full Text] [Related]

  • 2. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B.
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [Abstract] [Full Text] [Related]

  • 3. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
    Kiani R, Johnson D, Nelson B.
    Am J Med; 1988 Sep 16; 85(3A):6-13. PubMed ID: 3048092
    [Abstract] [Full Text] [Related]

  • 4. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
    Markham A, Brogden RN.
    Drugs; 1995 Jun 16; 49(6):1007-22. PubMed ID: 7641600
    [Abstract] [Full Text] [Related]

  • 5. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD, Brogden RN.
    Drugs; 1997 Jun 16; 53(6):973-1004. PubMed ID: 9179528
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ, Perry CM.
    Am J Respir Med; 2003 Jun 16; 2(2):175-201. PubMed ID: 14720016
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L, Hassman J, Tellier G.
    Clin Ther; 2004 Jan 16; 26(1):48-62. PubMed ID: 14996517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N, Nakamura H, Kasai K, Ozaki T, Matsui Y, Tauchi N, Yamaguchi H, Taneda Y, Maki T.
    Jpn J Antibiot; 1991 Jan 16; 44(1):35-47. PubMed ID: 2041146
    [Abstract] [Full Text] [Related]

  • 12. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR, Huang WK, Shyr JM, Lau YJ, Liu YC, Luh KT.
    J Formos Med Assoc; 2004 Sep 16; 103(9):664-70. PubMed ID: 15361938
    [Abstract] [Full Text] [Related]

  • 13. Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
    Salvarezza CR, Mingrone H, Fachinelli H, Kijanczuk S.
    J Antimicrob Chemother; 1998 Mar 16; 41 Suppl B():75-80. PubMed ID: 9579717
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D, Glaser-Caldow E, Wachter J, Brueckner OJ, Hein J, Kroemer B, Hirsch J.
    Clin Ther; 2001 Apr 16; 23(4):585-95. PubMed ID: 11354392
    [Abstract] [Full Text] [Related]

  • 15. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
    Sokol WN, Sullivan JG, Acampora MD, Busman TA, Notario GF.
    Clin Ther; 2002 Apr 16; 24(4):605-15. PubMed ID: 12017405
    [Abstract] [Full Text] [Related]

  • 16. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P, Mangunnegoro H, Yunus F, Gunawan J.
    Respirology; 1998 Jun 16; 3(2):113-7. PubMed ID: 9692520
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
    Modai J.
    Presse Med; 1989 Oct 11; 18(32):1605-7. PubMed ID: 2530543
    [Abstract] [Full Text] [Related]

  • 18. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
    Anzueto A, Niederman MS, Tillotson GS.
    Clin Ther; 1998 Oct 11; 20(5):885-900. PubMed ID: 9829441
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.
    Anzueto A, Niederman MS, Haverstock DC, Tillotson GS.
    Clin Ther; 1997 Oct 11; 19(5):989-1001. PubMed ID: 9385486
    [Abstract] [Full Text] [Related]

  • 20. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
    Piippo T, Stefansson S, Pitkäjärvi T, Lundberg C.
    Scand J Infect Dis; 1991 Oct 11; 23(4):459-65. PubMed ID: 1957129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.